Author: Ryan Pang, MD
Editor: Philippe Ayres, MD
A 72-year-old male with a past medical history of hypertension, diabetes, and hyperlipidemia presents to the ED with 3 months of chronic, progressively worsening swelling of his left arm. He also reports an inability to move his left arm and generalized malaise that has prevented his activities of daily living.
The initial vital signs are normal.
Physical exam reveals dry mucous membranes, and swelling of the left arm with an area of tenderness, fluctuance, erythema, and induration on the posterolateral aspect of the proximal extremity. It is oozing sanguineous, foul-smelling fluid. Active and passive range of motion of the extremity is limited due to pain, with preserved range of motion of the fingers and wrists. Radial pulses are 2+ bilaterally.
Point-of-care-ultrasound (POCUS) of the swollen area reveals a 4 x 4.5 cm pocket of heterogeneous fluid. An official DVT study of the left upper extremity is negative for deep vein thrombosis. The ED team performs incision and drainage and there is copious drainage of foul-smelling, bloody, gray fluid. The I&D is terminated early, a pressure dressing is applied, and a CTA of the left upper extremity is obtained to rule out aneurysm.
CTA reveals signs of necrotizing fasciitis with extensive collections of gas and fluid extending across fascial planes from the left chest and shoulder into the left upper extremity. The patient is started on vancomycin, piperacillin/tazobactam, and clindamycin for broad-spectrum coverage and inhibition of S. aureus and S. pyogenes toxin production.[1] General surgery promptly takes the patient to the OR for emergent I&D and washout of left upper extremity and left chest.
Of Note: Dr. Franck goes into more detail about the pathophysiology, diagnosis, and management of NF: Everything You Ever Wanted to Know About Necrotizing Fasciitis. Today, we will delve deeper into the utility of bedside testing for clinical diagnosis of NF, specifically discussing the use of POCUS and the “finger test”. Another bedside test, which is the frozen section biopsy will not be discussed in this blog post since it is beyond the scope of EM.
Necrotizing fasciitis (NF) is a rare, but serious infection involving the subcutaneous tissue and fascia of the body. The culprit organisms are gram-positive, gram-negative, aerobic, and/or anaerobic bacteria, and sometimes even fungi, NF may become fulminant, leading to extensive destruction of tissue, systemic toxicity, limb loss, and even death (mortality rate ranging from 20% to 80%).[2] Although laboratory testing, scores, and imaging may aid in the diagnosis, NF is a clinical diagnosis. Furthermore, since surgery is the definitive treatment for NF, blood testing and imaging should not delay surgical consultation. Below is a well-summarized table of all the clinical signs of NF.
Laboratory testing is not specific, and different scores that include vital signs and laboratory values have tried to distinguish NF from other soft tissue infections.
The most common score is the LRINEC score. In the original retrospective study by Wong et al., the LRINEC score utilized WBC, CRP, Hgb, Na, Cr, and glucose to risk stratify 89 patients who initially did not meet criteria for severe soft tissue infection (clinical impression of severe infection based on documentation, the use of parenteral antibiotics for ≥48 hours, and abscesses [when present] needing surgical debridement), but were later diagnosed with NF. A score of 8 and above is considered high risk, 6 and above is considered intermediate risk, and 5 and below is considered low risk for NF. In the study, a LRINEC score of 6 and above had a sensitivity of 89% (95% CI, 81.7–95.3), a specificity of 97% (95% CI, 93.7–98.7), a positive predictive value of 92% (95% CI, 84.3–96.0) and a negative predictive value of 96% (95% CI, 92.6–97.9). Of note, 7% to 10% of patients with NF were stratified by this score as “Low Risk”.[4]
Though the LRINEC score may be somewhat useful in ruling in NF, it is not reliable in ruling out NF, especially in light of more recent validation studies, including a prospective study by Hsiao et al., and a systematic review and meta-analysis by Fernando et al. These studies found the LRINEC score to have even lower sensitivities than in the original study, with LRINEC scores of 6 and above having sensitivities of 43% to 68% and specificities of 60% to 85%.[5,6,7]
Attempts have been made to propose other scoring systems, such as a score by Wall et al. that ruled in NF if patients had a WBC count > 15.4 and/or Na <135 mmol/L, or the NAS score proposed by Harasawa et al. that utilized MAP, CRP, Hgb, Cr, and glucose in risk stratifying patients with NF. The Wall et al. study, unfortunately, was a small sample size retrospective study conducted at a single center, thus limiting the utility of the scoring system. Additionally, a later retrospective comparative study of the usefulness of this score showed a poor sensitivity of 24% and a positive predictive value of 23%.[7,8]
The NAS score (seen in table 2) in the paper by Harasawa et al. does not include WBC count or Na in its score. Rather it uses vital signs, MAP, and other lab values, to risk stratify 104 patients with soft tissue infections for having NF. In the NAS score, a score of 6 and above is considered high risk and a score of 5 and below is considered low risk for NF. In the study, a NAS score of 6 had a sensitivity of 87.5%, specificity of 91.3%, positive predictive value of 75.0%, and negative predictive value of 96.1%. This study also compared NAS to the LRINEC score, with LRINEC having a sensitivity of 87.5%, specificity of 80%, positive predictive value of 56.8%, and negative predictive value of 95.5%. Though comparable to the LRINEC score, it is important to note that the NAS score does not have any prospective validation studies as of yet.[9]
Ultimately, NF is a clinical diagnosis. No scoring system can definitively rule in or out NF. A higher LRINEC score may prompt a sense of urgency in your surgery colleagues to evaluate your patient before completion of imaging, especially if initial clinical signs of NF are equivocal.
No imaging can definitively rule out NF, and different modalities of imaging offer various sensitivities in detecting NF.
X-Ray:
- Adds little value in the diagnosis of NF as early NF may be mistaken for cellulitis on radiographs, with the common finding of soft tissue thickening and increased opacity.[10]
- Although the late classical finding of dissecting gas along fascial planes in the absence of trauma may be a specific sign for NF, it is only seen in 25% to 55.0% of patients.[10]
- X-rays may be more sensitive than physical exams in the detection of soft-tissue gas, with radiographic findings being present before detectable clinical crepitus, but their utility for detecting deep fascial gas is limited.[10,11]
CT:
- CT imaging without contrast will show asymmetric fascial thickening and fat stranding and is more sensitive than X-rays in aiding the diagnosis of NF with a sensitivity of 80%.[10] CT imaging with contrast will show fascial involvement and lack of enhancement of the fascia and has a sensitivity of >92%.[12] The most specific finding, gas within fluid collections along subfascial planes, is better visualized on CT than X-ray, but is present in less than 55% of cases.[13,14]
MR:
- MR is the most sensitive modality with a sensitivity of >93%.[13,14] When MR detects a large, low-signal foci of gas, there is a specificity of 100%, though sensitivity in these cases are around 43%.[13] Additionally, the absence of deep fascial abnormality on MR was found to have a high negative predictive value.[15]
- Although MR imaging has a higher sensitivity compared to CT, it is important to consider the benefits of CT over MR, including speed, cost, ease of use, and greater accessibility for patients with metal implants.
Point-of-Care Ultrasound:
The main advantage of POCUS is that it can be done at bedside and aid in the diagnosis of NF without the need to wait for lab results and CT/MR imaging. Additionally, POCUS was found to have a sensitivity of 88.2% (95% CI, 63.6–98.5), specificity of 93.3% (95% CI, 81.7–98.6), positive predictive value of 83.3% (95% CI, 58.6–96.4), negative predictive value of 95.4% (95% CI, 84.5–99.4), and accuracy of 91.9% (95% CI, 82.2–97.3) in regards to the diagnosis of NF.[16] Viewing the suspected area of involvement with a linear probe, common POCUS findings characteristic of NF are subcutaneous tissue thickening, fascial thickening, fascial fluid, subcutaneous air, and abnormal muscle architecture.[17,18,19] Subcutaneous tissue thickening is referred to as “cobblestoning” and is characterized by thickening and increased echogenicity of the hypodermal tissue, which is crossed by thin ribbons of hypoechoic tissue that dissociate the fat lobules;[14] subcutaneous air can be seen as multiple echogenic foci with posterior “dirty acoustic shadowing” (as opposed to clean, uniform shadowing)[10] as shown in figure 1.
Additionally, you can further risk stratify patients for NF based on the depth of perifascial fluid detected on ultrasound, with the best cut-off reported to be 2 mm of fluid accumulation - this has a sensitivity of 75% and a specificity of 70.2%.[17] Increasing depth of fluid increases specificity as seen in Table 3. You can see examples of perifascial flail, fascial thickening, and distorted muscle architecture in Figures 2 and 3.The “Finger Test:”
Another bedside test you can utilize is the “finger test”, which has a sensitivity of 100% (95% CI, 69.2–100), a specificity of 80% (95% CI, 59.3–93.2), a positive predictive value of 66.7% (95% CI, 38.4–88.2), a negative predictive value of 100% (95% CI, 83.2–100), and an overall accuracy of 85.7% (95% CI, 69.7–95.2).[21] To perform the “finger test”, first infiltrate the area of suspected involvement with local anesthesia, make a 2-cm incision down to the deep fascia, then gently probe the area with your index finger.[22,23] The presence of characteristic “gray-dishwater discharge”, lack of bleeding on tissue surgical dissection, and minimal tissue resistance to blunt finger dissection are all positive findings correlated with NF.[22,23,24]
The patient was taken to the OR four times for debridement, partial closure, re-exploration, and wound vac placement. Blood cultures grew Group A strep and Methicillin Resistant Staph epidermidis, and abscess cultures grew Peptostreptococcus asaccharolyticus; the antibiotic regimen was tailored to treat these specific microbes. On hospital day 12, the patient was transferred to another hospital for plastic surgery skin grafting and was ultimately discharged to subacute rehab after a 23-day hospitalization.
1. Necrotizing fasciitis is an emergency which requires emergent surgical intervention.
2. The diagnosis of necrotizing fasciitis is mainly clinical, and no scoring tool can effectively rule out necrotizing fasciitis nor trump clinical suspicion.
3. Know the common clinical findings of necrotizing fasciitis (Table 1).
4. Laboratory testing and X-ray/CT/MR imaging modalities are limited for diagnosing necrotizing fasciitis.
5. Dirty dishwater discharge on finger test, dirty shadowing on ultrasound, and perifascial fluid >2 mm on POCUS may aid in the clinical diagnosis of necrotizing fasciitis.
1. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9(5):281-290. doi:10.1016/S1473-3099(09)70066-0
2. Wallace HA, Perera TB. Necrotizing Fasciitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 21, 2023.
3. Puvanendran R, Huey JC, Pasupathy S. Necrotizing fasciitis. Can Fam Physician. 2009;55(10):981-987.
4. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. doi:10.1097/01.ccm.0000129486.35458.7d
5. Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC. Prospective Validation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score for Necrotizing Fasciitis of the Extremities [published correction appears in PLoS One. 2022 Jun 24;17(6):e0270726. doi: 10.1371/journal.pone.0270726]. PLoS One. 2020;15(1):e0227748. Published 2020 Jan 24. doi:10.1371/journal.pone.0227748
6. Fernando SM, Tran A, Cheng W, et al. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. Ann Surg. 2019;269(1):58-65. doi:10.1097/SLA.0000000000002774
7. Thomas AJ, Meyer TK. Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis. Laryngoscope. 2012;122(12):2683-2687. doi:10.1002/lary.23680
8. Wall DB, Klein SR, Black S, de Virgilio C. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000;191(3):227-231. doi:10.1016/s1072-7515(00)00318-5
9. Harasawa T, Kawai-Kowase K, Tamura J, Nakamura M. Accurate and quick predictor of necrotizing soft tissue infection: Usefulness of the LRINEC score and NSTI assessment score. J Infect Chemother. 2020;26(4):331-334. doi:10.1016/j.jiac.2019.10.007
10. Tso DK, Singh AK. Necrotizing fasciitis of the lower extremity: imaging pearls and pitfalls. Br J Radiol. 2018;91(1088):20180093. doi:10.1259/bjr.20180093
11. Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008;28(2):519-528. doi:10.1148/rg.282075048
12. Carbonetti F, Cremona A, Carusi V, et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med. 2016;121(2):106-121. doi:10.1007/s11547-015-0575-4
13. Alaia EF, Chhabra A, Simpfendorfer CS, et al. MRI nomenclature for musculoskeletal infection [published correction appears in Skeletal Radiol. 2022 May;51(5):1103-1104]. Skeletal Radiol. 2021;50(12):2319-2347. doi:10.1007/s00256-021-03807-7
14. Malghem J, Lecouvet FE, Omoumi P, Maldague BE, Vande Berg BC. Necrotizing fasciitis: contribution and limitations of diagnostic imaging. Joint Bone Spine. 2013;80(2):146-154. doi:10.1016/j.jbspin.2012.08.009
15. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol. 1998;170(3):615-620. doi:10.2214/ajr.170.3.9490940
16. Yen ZS, Wang HP, Ma HM, Chen SC, Chen WJ. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002;9(12):1448-1451. doi:10.1197/aemj.9.12.1448
17. Fozard J, Shafer K, Kehrl T. Sonographic exploration for fascial exploration (SEFE) in necrotizing fasciitis: a case report. Ultrasound J. 2020;12(1):24. Published 2020 Apr 22. doi:10.1186/s13089-020-00168-5
18. Castleberg E, Jenson N, Dinh VA. Diagnosis of necrotizing faciitis with bedside ultrasound: the STAFF Exam. West J Emerg Med. 2014;15(1):111-113. doi:10.5811/westjem.2013.8.18303
19. Oelze L, Wu S, Carnell J. Emergency ultrasonography for the early diagnosis of necrotizing fasciitis: a case series from the ED. Am J Emerg Med. 2013;31(3):. doi:10.1016/j.ajem.2012.09.026
20. Gibbons RC. Necrotizing Soft Tissue Infection. Manifold projects. July 2020. Accessed May 19, 2024. https://manifold.escholarship.org/read/17103563-a6b2-4f9a-b36d-8e2515178699/section/2e4d0dc9-cbe2-4373-a89c-fedfb8022c57.
21. Lau JK, Kwok K, Hung Y, Fan C. Validation of finger test for necrotising soft tissue infection. Journal of Orthopaedics, Trauma and Rehabilitation. 2020;0(0). doi:10.1177/2210491720961546
22. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36. Published 2014 Sep 29. doi:10.3389/fsurg.2014.00036
23. Andreasen TJ, Green SD, Childers BJ. Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg. 2001 Apr 1;107(4):1025-35. doi: 10.1097/00006534-200104010-00019. PMID: 11252099.
24. Kaafarani HM, King DR. Necrotizing skin and soft tissue infections. Surg Clin North Am. 2014;94(1):155-163. doi:10.1016/j.suc.2013.10.011
25. William D. Harrison, Birender Kapoor. Necrotizing soft tissue infection: principles of diagnosis and management. Orthopaedics and Trauma. 2016;30(3): 223-231. doi:10.1016/j.mporth.2016.05.001
26. Stevens DL. Necrotizing soft tissue infections. In: Post TW, ed. UpToDate. UpToDate; 2024. Accessed May 16, 2024. https://www-uptodate-com.newproxy.downstate.edu/contents/necrotizing-soft-tissue-infections search=necrotizing%20fasciitis&source=search_result&selectedTitle=1%7E149&usage_type=default&display_rank=1
27. Fugitt JB, Puckett ML, Quigley MM, Kerr SM. Necrotizing fasciitis. Radiographics. 2004;24(5):1472-1476. doi:10.1148/rg.245035169
payresmatch
Latest posts by payresmatch (see all)
- “Talk Dirty to Me”: Bedside Testing for Necrotizing Fasciitis - November 5, 2024
- AV Dissociation and Complete AV Block: What’s the Difference? - July 30, 2024
- Cutting it Close: One Decision, Two Lives - May 31, 2024
1 Comment
nicanthony · November 5, 2024 at 9:51 am
Great POCUS images!!!!